FDA rejects Pfizer’s Herceptin biosimilar
US regulators have issued a complete response letter regarding Pfizer’s filing for a biosimilar version of Roche’s blockbuster cancer drug Herceptin.
Read More
Tag: Trumenba
UK launch for Pfizer’s MenB jab Trumenba
Pfizer’s new meningitis B vaccine Trumenba is now available in the UK for teens and young adults providing an additional option for vaccination against the disease.
Read More
EU nod for Pfizer’s men B jab Trumenba
Pfizer’s Trumenba has been cleared by European regulators to help prevent infection with meningococcal group B disease in adolescents and adults.
Read More
Six new medicines backed for EU approval
Six new medicines, including three orphan drugs for rare diseases, have been backed for European Union approval by the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP).
Read More
- Fabentech secures French approval for Ricimed antidote
- Oxford Drug Design reports major in vivo milestone for novel cancer therapy
- Storm Therapeutics and AlidaBio launch collaboration to advance RNA‑targeting cancer therapies
- Excellence adventure
- MHRA approves Nucala for eosinophilic COPD in adults on triple therapy
